PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY END-USER • Segmentation by end-user • Comparison by end-user • Pharmaceutical and biotechnology companies – Market size and forecast 2017-2022 • Academic and research institutes – Market size and forecast 2017-2022 • CROs – Market size and forecast 2017-2022 • Market opportunity by end-user PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas – Market size and forecast 2017-2022 • EMEA – Market size and forecast 2017-2022 • APAC – Market size and forecast 2017-2022 • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Increasing focus on promotional activities • Growth in outsourcing activities • Increasing research activities in stem cells • Technological advances PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Agilent Technologies • Bio-Rad Laboratories • Charles River • Merck KGaA • PerkinElmer • Thermo Fisher Scientific PART 15: APPENDIX • List of abbreviations Exhibit 01: Parent market Exhibit 02: Global pharmaceutical market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global HTS market – Market size and forecast 2017-2022 ($ bn) Exhibit 09: Global HTS market – Year-over-year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2017 Exhibit 18: End-user – Market share 2017-2022 (%) Exhibit 19: Comparison by end-user Exhibit 20: Pharmaceutical and biotechnology companies – Market size and forecast 2017-2022 ($ bn) Exhibit 21: Pharmaceutical and biotechnology companies – Year-over-year growth 2018-2022 (%) Exhibit 22: Academic and research institutes – Market size and forecast 2017-2022 ($ bn) Exhibit 23: Academic and research institutes – Year-over-year growth 2018-2022 (%) Exhibit 24: CROs – Market size and forecast 2017-2022 ($ bn) Exhibit 25: CROs – Year-over-year growth 2018-2022 (%) Exhibit 26: Market opportunity by end-user Exhibit 27: Customer landscape Exhibit 28: Global HTS market – Market share by geography 2017-2022 (%) Exhibit 29: Regional comparison Exhibit 30: Americas – Market size and forecast 2017-2022 ($ bn) Exhibit 31: Americas – Year-over-year growth 2018-2022 (%) Exhibit 32: Top 3 countries in Americas Exhibit 33: EMEA – Market size and forecast 2017-2022 ($ bn) Exhibit 34: EMEA – Year-over-year growth 2018-2022 (%) Exhibit 35: Top 3 countries in EMEA Exhibit 36: APAC – Market size and forecast 2017-2022 ($ bn) Exhibit 37: APAC – Year-over-year growth 2018-2022 (%) Exhibit 38: Top 3 countries in APAC Exhibit 39: Market opportunity Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: Agilent Technologies overview Exhibit 46: Agilent Technologies – Business segments Exhibit 47: Agilent Technologies – Organizational developments Exhibit 48: Agilent Technologies – Geographic focus Exhibit 49: Agilent Technologies – Segment focus Exhibit 50: Agilent Technologies – Key offerings Exhibit 51: Bio-Rad Laboratories overview Exhibit 52: Bio-Rad Laboratories – Business segments Exhibit 53: Bio-Rad Laboratories – Organizational developments Exhibit 54: Bio-Rad Laboratories – Geographic focus Exhibit 55: Bio-Rad Laboratories – Segment focus Exhibit 56: Bio-Rad Laboratories – Key offerings Exhibit 57: Charles River overview Exhibit 58: Charles River – Business segments Exhibit 59: Charles River– Organizational developments Exhibit 60: Charles River – Geographic focus Exhibit 61: Charles River – Segment focus Exhibit 62: Charles River – Key offerings Exhibit 63: Merck KGaA overview Exhibit 64: Merck KGaA – Business segments Exhibit 65: Merck KGaA – Organizational developments Exhibit 66: Merck KGaA – Geographic focus Exhibit 67: Merck KGaA – Segment focus Exhibit 68: Merck KGaA – Key offerings Exhibit 69: PerkinElmer overview Exhibit 70: PerkinElmer – Business segments Exhibit 71: PerkinElmer – Organizational developments Exhibit 72: PerkinElmer – Geographic focus Exhibit 73: PerkinElmer – Segment focus Exhibit 74: PerkinElmer – Key offerings Exhibit 75: Thermo Fisher Scientific overview Exhibit 76: Thermo Fisher Scientific – Business segments Exhibit 77: Thermo Fisher Scientific – Organizational developments Exhibit 78: Thermo Fisher Scientific – Geographic focus Exhibit 79: Thermo Fisher Scientific – Segment focus Exhibit 80: Thermo Fisher Scientific – Key offerings

Agilent Technologies Bio-Rad Laboratories Charles River Merck KGaA PerkinElmer Thermo Fisher Scientific